Research Topics
| A L NelsonSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
The intrauterine contraceptive deviceA L Nelson
Department of Obstetrics and Gynecology, University of California Los Angeles School of Medicine, USA
Obstet Gynecol Clin North Am 27:723-40. 2000..The introduction of new IUDs with different side-effect profiles will expand the number of US women who can and will be interested in using this method of birth control...- Reversible female contraception: current options and new developmentsAnita L Nelson
Obstetrics and Gynecology, Harbor UCLA Medical Center, Torrance, CA 90266 6335, USA
Expert Rev Med Devices 4:241-52. 2007..This review briefly discusses existing contraceptive methods and new developments that are under investigation... - Medical therapies for chronic menorrhagiaAnita L Nelson
Department of Obstetrics and Gynecology, David Geffen School of Medicine, Harbor UCLA Medical Center, Torrance, California 90509 2910, USA
Obstet Gynecol Surv 62:272-81. 2007..Increased use of effective medical therapies has the potential to reduce the number of surgical procedures, such as endometrial ablation and hysterectomy... - Extended-cycle oral contraception: a new option for routine useAnita L Nelson
Harbor UCLA Medical Center, Torrance, California 90209 2910, USA
Treat Endocrinol 4:139-45. 2005..Every woman who is interested in using OC pills should be offered the opportunity to choose how to use them, to determine if and when she will have withdrawal bleeding... - Contraindications to IUD and IUS useAnita L Nelson
Harbor UCLA Medical Center, Box 474, Torrance, CA 90509 2910, USA
Contraception 75:S76-81. 2007.... - Ambulatory diagnosis and medical management of ectopic pregnancy in a public teaching hospital serving indigent womenAnita L Nelson
Department of Obstetrics and Gynecology and the Research and Education Institute at Harbor UCLA Medical Center, Torrance, 90509 2920, USA
Am J Obstet Gynecol 188:1541-7; discussion 1547-50. 2003..The study was undertaken to evaluate the outcomes of indigent women with possible ectopic pregnancy who were cared for in a public teaching hospital outpatient clinic by multiple residents... - Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuationAnita L Nelson
Department of Obstetrics and Gynecology, David Geffen School of Medicine, Harbor UCLA Medical Center, Torrance, California 90509 2910, USA
Obstet Gynecol 112:782-7. 2008..The objective was to describe timely refills of hormonal contraceptive products among a large, geographically diverse population of U.S. women as an estimate of method continuation over time... - Accuracy of information given by Los Angeles County pharmacies about emergency contraceptives to sham patient in needAnita L Nelson
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90509 2910, USA
Contraception 79:206-10. 2009..As emergency contraception (EC) becomes increasingly available without prescription, it is important that women in need be provided accurate information about its use... - Intraoperative placement of the Copper T-380 intrauterine devices in women undergoing elective cesarean delivery: a pilot studyAnita L Nelson
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90509 2910, USA
Contraception 80:81-3. 2009.... - Extended-cycle oral contraceptive pills with 10 microg ethinyl estradiol pills in place of placebo pillsAnita L Nelson
Harbor UCLA Medical Center, Torrance, CA, USA
Womens Health (Lond Engl) 3:529-35. 2007.... - The importance of patient and healthcare provider perceptions in the evaluation of imiquimod and other prior treatments for anogenital wartsAnita L Nelson
Department of Obstetrics and Gynecology, Harbor UCLA Medical Center, University of California Los Angeles, 1000 West Carson Street, Box 474, Torrance, CA 90509 2910, USA
Int J STD AIDS 13:29-35. 2002..Therefore, comparative studies should include assessments of these perceptions to gain a full understanding of the relative merits of the therapies under investigation... - Assessment of urgent and ongoing contraceptive needs in an OB/GYN urgent care settingMonica Perez
Department of Obstetrics and Gynecology, Harbor UCLA Medical Center, Torrance, CA 90509, USA
Contraception 75:108-11. 2007..Even when women seek care, their acute needs for those interventions may not be assessed... - Levonorgestrel intrauterine system: a first-line medical treatment for heavy menstrual bleedingAnita L Nelson
David Geffen School of Medicine at UCLA, Torrance, CA, USA
Womens Health (Lond Engl) 6:347-56. 2010.... - Subject and clinician experience with the levonorgestrel-releasing intrauterine systemJeffrey T Jensen
Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
Contraception 77:22-9. 2008.... - Communicating with patients about extended-cycle and continuous use of oral contraceptivesAnita L Nelson
Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Torrance, California 90509 2910, USA
J Womens Health (Larchmt) 16:463-70. 2007..Good clinician-patient communication, which includes creating an open dialogue with the patient to discuss her individual risks and benefits, should lead to more successful contraceptive utilization... - Initiation and continuation rates seen in 2-year experience with Same Day injections of DMPAAnita L Nelson
Department of Obstetrics and Gynecology, Los Angeles Biomedical Research, Institute at Harbor UCLA Medical Center, Torrance, CA 90509, USA
Contraception 75:84-7. 2007..The Same Day injection protocol is comprehensive and includes emergency contraception, backup methods for 7 days and repeat pregnancy testing within 2-3 weeks... - Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patternsLori D Halderman
Department of Obstetrics and Gynecology, Harbor-University of California, Los Angeles, Medical Center, USA
Am J Obstet Gynecol 186:1250-6; discussion 1256-8. 2002..CONCLUSION: This study demonstrates that there is no detectable adverse impact on breast-feeding attributable to progestin-only contraceptive methods initiated within the first 3 days post partum... - Recent developments in hormone delivery systemsLee P Shulman
Department of Obstetrics and Gynecology, Feinberg School of Medicine at Northwestern University, Chicago, IL 60611, USA
Am J Obstet Gynecol 190:S39-48. 2004..Finally, hormonal implants that release low doses of progestins have been used for more than 30 years by a total of 10 million women, and easier-to-use implants will soon be available... - Documented short-term continuation rates for combined hormonal contraceptives in an indigent population with ready access to contraceptive suppliesAnita L Nelson
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA, USA
Am J Obstet Gynecol 196:599.e1-5; discussion 599.e5-6. 2007.... - Extended-regimen contraception: effects on menstrual symptoms and quality of lifeAnita L Nelson
Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA
J Fam Pract 55:S1-8. 2006 - Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosteroneI T Gaw Gonzalo
Division of Endocrinology, Department of Medicine, Harbor-University of California at Los Angeles Medical Center and Research and Education Institute, Torrance, California 90509, USA
J Clin Endocrinol Metab 87:3562-72. 2002..This study demonstrates that the dose or route of administration of androgens is critical for sperm suppression in combined androgen-progestagen regimens for hormonal male contraception... - Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese menChristina Wang
General Clinical Research Center, Harbor UCLA Medical Center, 1000 W Carson Street, Torrance, CA 90509, USA
J Clin Endocrinol Metab 91:460-70. 2006..Previous male contraceptive studies showed that progestins enhance spermatogenesis suppression by androgens in men... - Intermediate-term glucose tolerance in women with a history of gestational diabetes: natural history and potential associations with breastfeeding and contraceptionAnita L Nelson
Department of Obstetrics and Gynecology, Harbor UCLA Medical Center, Torrance, CA, USA
Am J Obstet Gynecol 198:699.e1-7; discussion 699.e7-8. 2008..The association between deterioration of glucose metabolism and contraceptive methods was also studied... - Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perceptionDaniel R Mishell
Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
Contraception 75:4-10. 2007.... - Recent use of condoms and emergency contraception by women who selected condoms as their contraceptive methodAnita L Nelson
Division of Gynecology, Department of Obstetrics and Gynecology, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USA
Am J Obstet Gynecol 194:1710-5; discussion 1715-6. 2006..Patients may be reluctant to volunteer to clinicians their real contraceptive choices. Risk taking occurs at high rates, even among couples provided ready and free access to male condoms and EC... - Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trialTerri L Walsh
Research Division, California Family Health Council, Los Angeles, USA
Perspect Sex Reprod Health 35:79-86. 2003..To reduce unintended pregnancy and HIV infection, it is critical to develop reliable male condoms that will attract consumers who reject conventional latex condoms... - Use of prostate-specific antigen (PSA) to measure semen exposure resulting from male condom failures: implications for contraceptive efficacy and the prevention of sexually transmitted diseaseTerri L Walsh
Research Division, California Family Health Council, 3600 Wilshire Boulevard, Suite 600, Los Angeles, CA 90010 2610, USA
Contraception 67:139-50. 2003..We also used PSA results to adjust a model designed to predict consistent-use pregnancy rates from condom breakage and slippage data... - Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral densityChristine C Johnson
Henry Ford Hospital, Detroit, MI 48202 3450, USA
Contraception 77:239-48. 2008..nonuse of the injectable (intramuscular) contraceptive depot medroxyprogesterone acetate (DMPA-IM) and its effect on bone mass in adolescent women...